Calcineurin Inhibitors and COVID-19.

Hage, René; Schuurmans, Macé M

Hage, René; Schuurmans, Macé M.

Afiliação

Hage R; University Hospital Zurich, Division of Pulmonology, Raemistrasse 100, 8091 Zurich, Switzerland; University of Zurich, Faculty of Medicine, Raemistrasse 71, 8006 Zurich, Switzerland. Electronic address: rene.hage@usz.ch.
Schuurmans MM; University Hospital Zurich, Division of Pulmonology, Raemistrasse 100, 8091 Zurich, Switzerland; University of Zurich, Faculty of Medicine, Raemistrasse 71, 8006 Zurich, Switzerland.

Reumatol Clin (Engl Ed) ; 18(5): 314-315, 2022 05.

Article em En | MEDLINE | ID: mdl-35568446

Assuntos

COVID-19; Inibidores de Calcineurina; Inibidores de Calcineurina/farmacologia; Inibidores de Calcineurina/uso terapêutico; Humanos; Imunossupressores/efeitos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Calcineurina / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google